Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
IV Iron Treatments Linked To Anaphylaxis Risk: Study Injectafer fared better than the competing IV iron supplements, Dexiron and Feraheme, which were three to eight times more likely to cause anaphylaxis. March 31, 2022 Irvin Jackson Add Your Comments Side effects of intravenous iron treatments, like Injectafer, Dexiron and Feraheme, may include a risk of serious and life-threatening allergic reactions, according to the findings of a new study. In findings published this week in the Annals of Internal Medicine, researchers from the Rutgers University note that the overall risk of anaphylaxis from iron IV supplementation is low, but some products have notably higher rates than their competitors, particularly Dexiron and Feraheme. Iron IV infusions are often given to adults with anemia, who are not able to be treated with an oral iron supplement. In this latest study, researchers compared the risks for anaphylaxis among several, frequently used, IV iron products. They looked at Medicare fee-for-service data from between July 2013 and December 2018 involving older adults who suffered anaphylaxis on the first day of IV iron administration. According to the findings, there were 9.8 cases of anaphylaxis for every 10,000 first administrations linked to Dexiron (iron dextran); and four cases per 10,000 involving Feraheme (ferumoxytol). That compares to 1.2 cases per 10,000 first administrations with iron sucrose, which was used as the baseline referent category. Injectafer, one of the most widely used IV iron drugs, only had 0.8 cases per 10,000, giving it the lowest rate of anaphylaxis out of all the drugs tested, but the iron infusion did still carry a risk. “The rates of anaphylaxis were very low with all IV iron products but were 3- to 8-fold greater for iron dextran and ferumoxytol than for iron sucrose,” the researchers determined. Injectafer Blood Phosphorus Concerns The findings come amid increasing concerns about the side effects of Injectafer (ferric carboxymaltose), which was introduced in 2013 and has been linked to reports of severe hypophosphatemia (HPP), which is a medical condition associated with drops in blood phosphate levels, increasing the risk of severe health complications like cardiac arrest, respiratory failure and death. There are now a growing number of Injectafer lawsuits being pursued by individuals who experienced complications after an iron infusion, alleging that the drug makers failed to adequately warn about the risk and importance of blood phosphate testing after treatments, which can result in a serious and life-threatening medical emergency. Learn More About Injectafer Lawsuit Updates Side effects of the iron deficiency drug Injectafer may result in severely low phosphorous levels. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Injectafer Lawsuit Updates Side effects of the iron deficiency drug Injectafer may result in severely low phosphorous levels. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Plaintiffs pursuing lawsuits over the iron infusions allege the drug makers knew or should have known about the risks associated with their treatment, and placed the desire for profits before patient safety by minimizing the Injectafer FDA label warnings, previously suggesting that serum phosphate drops were “asymptomatic” or “transient.” While updated warnings were provided in February 2020, recommending doctors monitor serum phosphate levels among patients at risk of problems or requiring repeat courses of the iron infusion, a growing number of experts now suggest doctors should be encouraged to test blood phosphate levels for all patients. Severe HPP caused by Injectafer has also been linked to reports of bone fractures, heart rhythm problems, kidney problems and a host of other ailments caused by persistent and drops in blood phosphorous levels. Tags: Anaphylaxis, Dexiron, Feraheme, Injectafer, intravenous, Iron Deficiency, Severe HPP More Injectafer Lawsuit Stories Injectafer Fails to Prevent Heart Failure in Patients with Iron Deficiency, Study Finds August 29, 2023 Four Injectafer Lawsuits To Go Before Juries For Trial Dates Set to Begin in 2023 February 20, 2023 Iron Deficiency Infusion Lawsuit Filed Against Injectafer Manufacturers February 6, 2023 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 2 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 3 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025) Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: 4 days ago) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)
Injectafer Fails to Prevent Heart Failure in Patients with Iron Deficiency, Study Finds August 29, 2023
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 2 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 3 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: 4 days ago) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)